Treatment of preexisting diabetes with olanzapine

Journal of Clinical Psychiatry

Volumn 62, Issue 9, 2001, Pages 733-734

  Littrell, K H ^a   Petty, R G ^a   Peabody, C D ^a   Hilligoss, N M ^a   Johnson, C G ^a  

^a Promedica Research Center   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CLOZAPINE; GLIBENCLAMIDE; GLIMEPIRIDE; INSULIN; METFORMIN; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; TROGLITAZONE;

ADULT; CASE REPORT; CLINICAL FEATURE; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; HUMAN; INSULIN TREATMENT; LETTER; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0034772415     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0912a     Document Type: Letter

References (13)

1. Clozapine and associated diabetes mellitus
2. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications
3. Novel antipsychotics and new-onset diabetes
4. Diabetic ketoacidosis associated with clozapine treatment
5. Hyperglycemia associated with olanzapine
6. Olanzapine-induced ketoacidosis with diabetes mellitus
7. Acute-onset diabetic ketoacidosis during olanzapine treatment in a patient without pretreatment obesity or treatment-associated weight gain
8. Hyperglycemia and olanzapine
9. Diabetic ketoacidosis associated with olanzapine treatment
10. Olanzapine-induced glucose dysregulation
11. Atypical antipsychotic agents and diabetes mellitus
12. Switching clozapine responders to olanzapine